ELI LILLY & Co
Close on Nov 2, 2026Market cap $1.33TP/E 45.8Yield 0.44%
Eli Lilly Cymbalta (duloxetine) by Year
Cymbalta (duloxetine) — Worldwide revenue ($M) [legacy separate disclosure] ($M)
Eli Lilly Cymbalta (duloxetine): $283M in FY2022, down 51.3% from a year earlier. No newer figure appears in the documents we track.
Where the FY2022 figure comes from
“|| Cymbalta | 33.7 | 249.6 | 283.3 | 581.5 | (51)”
Source: Form 10-K FY2022 (filed 2023-02-22) ↗
Reported in Form 10-Q / 10-K Note 2 & MD&A (legacy separate product disclosure prior to FY2025 reorganization).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Cymbalta (duloxetine) — Worldwide revenue ($M) [legacy separate disclosure] ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2022 | Dec 31, 2022 | 283 | -51.3% | Form 10-K FY2022 (filed 2023-02-22) ↗ |
| FY2021 | Dec 31, 2021 | 582 | -24.3% | Form 10-K FY2021 (filed 2022-02-23) ↗ |
| FY2020 | Dec 31, 2020 | 768 | +8.4% | Form 10-K FY2020 (filed 2021-02-17) ↗ |
| FY2019 | Dec 31, 2019 | 708 | -6.5% | Form 10-K FY2019 (filed 2020-02-19) ↗ |
| FY2018 | Dec 31, 2018 | 757 | 0.0% | Form 10-K FY2018 (filed 2019-02-19) ↗ |
| FY2017 | Dec 31, 2017 | 757 | +332.7% | Form 10-K (filed 2018-02-20) ↗ |
| FY2016 | Dec 31, 2016 | 175 | – | Form 10-K (filed 2019-02-19) ↗ |
Breakdown
What makes up cymbalta (duloxetine)
Cite this data
StockData. (2026). Eli Lilly Cymbalta (duloxetine) ($M), annual FY2016–FY2022 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/med-cymbalta-ww
See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.